BackInAction: Acupuncture for Chronic Low Back Pain in Older Adults

Sponsor
Kaiser Permanente (Other)
Overall Status
Recruiting
CT.gov ID
NCT04982315
Collaborator
National Center for Complementary and Integrative Health (NCCIH) (NIH)
789
4
3
26.6
197.3
7.4

Study Details

Study Description

Brief Summary

The main goal of the BackInAction research study is to determine the effectiveness of a standard course of acupuncture (15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in older adults (65+ years) with chronic low back pain compared to usual care alone. Key secondary aims are to determine the effectiveness of acupuncture in improving a composite score of pain intensity and pain interference.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Standard Acupuncture
  • Procedure: Enhanced Acupuncture
N/A

Detailed Description

Background: A critical gap exists in evidence regarding the safety and effectiveness of treatments for older adults (65+ years) with chronic low back pain. Acupuncture has been found to be effective in treating chronic low back pain in younger adults. Yet trials have rarely included older adults, who have more comorbidities and may respond differently than typical trial participants. BackInAction has been designed to address this gap.

Purpose: The main goal of BackInAction is to evaluate the effectiveness of a standard course of acupuncture (up to 15 sessions of acupuncture over 3 months) and an enhanced course of acupuncture (up to an additional 6 sessions of acupuncture over months 4-6) in improving back-related disability in older adults with chronic low back pain compared to usual care alone. Key secondary aims are to determine the effectiveness of acupuncture in improving a composite score of pain intensity and pain interference.

Design and Outcomes: In this pragmatic, three-arm parallel groups multi-site randomized controlled trial, the investigators will recruit and randomize 789 adults ≥ 65 years of age with chronic low back to standard acupuncture, enhanced acupuncture, or usual medical care alone in four health-care systems. These include two integrated health care systems, a fee-for-service system and a network of federally qualified health centers. Primary outcome data will be collected by questionnaire at 3-, 6-, and 12-months post-randomization. In addition, short monthly surveys will capture data on physical function and a composite score of pain intensity and pain interference.

Interventions and Duration: Standard acupuncture will consist of 3 months (90 days) of acupuncture needling, with a proposed minimum of 8 treatments and a maximum of 15. Enhanced acupuncture will include the standard acupuncture plus an additional 3-month maintenance period, with a maximum of six additional treatments. Usual medical care will consist of the care that individuals receive according to their insurance benefits plus anything else they pay for out of pocket. The investigators will ask those assigned to usual medical care to avoid acupuncture for the year they are enrolled in the study. Both active treatment arms will also have access to usual medical care. Participants will be enrolled in the study for 12 months.

Sample Size and Population: BackInAction will include patients at least 65 years of age with uncomplicated chronic low back pain with or without radiculopathy. The investigators plan to enroll a total of 789 participants (263 per study arm). Participants will be recruited from four health plans, with varying numbers of participants from each site. Randomization will be stratified by health care system, age category and gender. The investigators expect the racial and ethnic mix will roughly parallel that of the older Medicare population.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
789 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pragmatic Trial of Acupuncture for Chronic Low Back Pain in Older Adults
Actual Study Start Date :
Aug 12, 2021
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Oct 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Standard Acupuncture

Participants randomized to standard acupuncture will receive 8-15 acupuncture treatments over 3 months.

Procedure: Standard Acupuncture
The standard acupuncture intervention is based on classical Chinese acupuncture therapy. Participants randomized to standard acupuncture will receive up to 15 acupuncture treatments over 3 months with the total number being determined by the patient and acupuncturist together. All treatments will include acupuncture needling only. They will be provided at medical facilities or in private acupuncturists' offices.

Experimental: Enhanced Acupuncture

Participants randomized to enhanced acupuncture will receive 12-21 acupuncture treatments over 6 months.

Procedure: Enhanced Acupuncture
The enhanced acupuncture intervention includes the 3 months of standard acupuncture plus an additional 3 months of maintenance acupuncture. Participants randomized to enhanced acupuncture will receive up to 21 acupuncture treatments over 6 months. The maintenance acupuncture treatment sessions are expected to consist of the same intervention used in the first 3 months of care described in the standard acupuncture arm, plus up to 6 treatments during the maintenance phase. All treatments will include acupuncture needling only. They will be provided at medical facilities or in private acupuncturists' offices.

No Intervention: Usual Care

Participants assigned to the usual care arm will not receive acupuncture and will be asked to not get acupuncture over the one-year course of the study.

Outcome Measures

Primary Outcome Measures

  1. Change in back-related disability at 6-month post randomization (continuous) [Baseline to 6-month]

    Change in back-related disability is defined as score change in Roland Morris Disability Questionnaire (RMDQ), a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.

Secondary Outcome Measures

  1. Change in back-related disability at 3-, and 12-month (continuous) [Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months]

    Change in back-related disability is defined as score change in RMDQ, a 24-item questionnaire which asked whether 24 specific activities were limited due to back pain during the past week. The RMDQ is scored from 0 to 24, with higher scores indicating more disability. Greater change between baseline and 6-months would indicate greater improvement.

  2. Achieving Minimal Clinically Important Difference (MCID) in back-related dysfunction at 3-, 6-, and 12-months (binary) [Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months]

    The MCID is measured by a 30% improvement (reduction) on the RMDQ. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% at each follow-up timepoint on the RMDQ.

  3. Change in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6- and 12-month (continuous) [Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months]

    Change in pain intensity and pain interference with enjoyment of life and general activity will be measured by PEG, a 3-item pain-intensity and pain-related interference composite measure assessing pain intensity, and pain interference with enjoyment of life and general activity. Each item is measured by a 0 to 10 scale with 10 indicating greater pain intensity or pain interference. The scores are then averaged with a higher average score indicating greater pain interference/intensity.

  4. Achieving MCID in Pain, Pain Interference with Enjoyment, General Activity (PEG) at 3-, 6-, and 12-months (binary) [Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months]

    The MCID is measured by a 30% improvement (reduction) on the PEG. Because the MCID reflects clinical improvement, this measure indicates what proportion of individuals in each study group improved at least 30% for a particular follow-up timepoint on the PEG.

  5. Change in physical functioning at 3-, 6- and 12-month (continuous) [Study primary outcome timepoint: Baseline to 6 months; Test of Standard Acupuncture: Baseline to 3 months; Test of Maintenance effect: Baseline to 12 months]

    Change in the Patient-Reported Outcomes Measurement and Information System (PROMIS) Physical functioning short form 6b from the PROMIS-29 (6 items). The 6-item Physical function scale measures self-reported ability to perform activities rather than the actual performance of those activities. Each question has five response options, ranging from one to five. Raw scores range from 6 to 30, with higher scores indicating greater ability. The scores are then standardized using a T-score metric in which 50 is the reference mean and 10 is the standard deviation (SD) of that population.

  6. Patient global impression of change (PGIC) at 3-, 6-, and 12- months [Study primary outcome timepoint: 6 months; Test of Standard Acupuncture: 3 months; Test of Maintenance effect: 12 months]

    Patient Global Impression of Change in Overall Pain (1 item). This is a 0 to 6 scale ranging from much worse to much better, with higher scores indicating more improvement.

  7. Serious Adverse Effects (SAE)/non-Serious Adverse Effects (AE) [SAE: 12 months from electronic health record data; AE: 12 months from acupuncture treatment records and follow-up interviews.]

    Serious Adverse Effects/non-Serious Adverse Effects attributed to acupuncture

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Is at least 65 years of age

  • Is a current member or patient of the healthcare system

  • Visited a health care provider for low back pain within the past 12 months

  • Received primary care at one of the participating health care systems

  • Has back pain that is uncomplicated with or without radicular pain

  • Back pain at least 3 months

  • General activity question from PEG (Pain, Pain Interference with Enjoyment, General Activity scale) at least 3

  • Primary care provider provides permission to contact patient

  • Willing and able to provide consent (Callahan cognitive impairment screener at least

Exclusion Criteria:
  • Specific types of back pain (metastatic cancer or bone cancer or secondary cancers, vertebral fractures, spinal infection, active inflammatory disease)

  • Low back surgery within past 3 months

  • Receiving workers compensation or involved in litigation related to chronic low back pain

  • Acupuncture within the last 6 months

  • Does not speak or write English or Spanish

  • Major psychosis, dementia

  • Current cancer treatment

  • Red flags of serious underlying illness (a fever most days in the last month; recent unexplained weight loss of 10 lbs or more)

  • Living in a nursing home, on Hospice, or palliative care

  • Non-speaking deafness

  • Non-reliable transportation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaiser Permanente Division of Research Oakland California United States 94612
2 Sutter Health Walnut Creek California United States 94596
3 Institute for Family Health New York New York United States 10035
4 Kaiser Permanente Washington Health Research Institute Seattle Washington United States 98103

Sponsors and Collaborators

  • Kaiser Permanente
  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

  • Principal Investigator: Lynn L DeBar, PhD, MPH, Kaiser Permanente
  • Principal Investigator: Karen J Sherman, PhD, MPH, Kaiser Permanente

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT04982315
Other Study ID Numbers:
  • BackInAction
  • UH3AT010739
First Posted:
Jul 29, 2021
Last Update Posted:
Jun 13, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kaiser Permanente
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 13, 2022